AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) is Buildings and Property in United Kingdom that focus on Arimidex business. They cover business area such as Arimidex, (anastrozole, Casodex, various european and african country.
-
Arimidex
-
Cambridge
England, United Kingdom
Private
Arimidex(anastrozoleCasodexvarious european and african country
* We use standard office opening hours in near AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
AstraZeneca (Arimidex And Casodex Commercial Rights In European And African Countries) is Buildings and Property business from United Kingdom that founded in - ( years old in ), AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) business is focusing on Arimidex.
AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) headquarter office and corporate office address is located in Cambridge England, United Kingdom.
AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) was founded in United Kingdom.
In , AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries) is currently focus on Arimidex sector.
Above is snippet of Google Trends for "Arimidex" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with AstraZeneca (Arimidex and Casodex Commercial Rights in European and African Countries), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
